Author:
Cust Anne E.,Slimani Nadia,Kaaks Rudolf,van Bakel Marit,Biessy Carine,Ferrari Pietro,Laville Martine,Tjønneland Anne,Olsen Anja,Overvad Kim,Lajous Martin,Clavel-Chapelon Francoise,Boutron-Ruault Marie-Christine,Linseisen Jakob,Rohrmann Sabine,Nöthlings Ute,Boeing Heiner,Palli Domenico,Sieri Sabina,Panico Salvatore,Tumino Rosario,Sacerdote Carlotta,Skeie Guri,Engeset Dagrun,Gram Inger Torhild,Quirós J. Ramón,Jakszyn Paula,Sánchez María José,Larrañaga Nerea,Navarro Carmen,Ardanaz Eva,Wirfält Elisabet,Berglund Göran,Lundin Eva,Hallmans Göran,Bueno-de-Mesquita H. Bas,Du Huaidong,Peeters Petra H. M.,Bingham Sheila,Khaw Kay-Tee,Allen Naomi E.,Key Timothy J.,Jenab Mazda,Riboli Elio
Publisher
Oxford University Press (OUP)
Reference63 articles.
1. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review;Kaaks;Cancer Epidemiol Biomarkers Prev,2002
2. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer;Lukanova;Int J Cancer,2004
3. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European Prospective Investigation into Cancer and Nutrition;Cust;Int J Cancer,2007
4. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women;Cust;J Clin Endocrinol Metab,2007
5. Central role of the adipocyte in insulin resistance;Bergman;J Basic Clin Physiol Pharmacol,1998